PROTAC-induced protein structural dynamics in targeted protein degradation

被引:0
|
作者
Wu, Kingsley Y. [1 ]
Hung, Ta, I [1 ,2 ]
Chang, Chia-en A. [1 ]
机构
[1] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA
[2] Univ Calif Riverside, Dept Bioengn, Riverside, CA USA
来源
ELIFE | 2025年 / 13卷
关键词
drug development; targeted protein degradation; structural dynamic; conformational sampling; molecular modeling; molecular mechanics; E3 UBIQUITIN LIGASE; MOLECULAR-DYNAMICS; COMPLEX; ACCURACY; DESIGN;
D O I
10.7554/eLife.101127
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
PROteolysis TArgeting Chimeras (PROTACs) are small molecules that induce target protein degradation via the ubiquitin-proteasome system. PROTACs recruit the target protein and E3 ligase; a critical first step is forming a ternary complex. However, while the formation of a ternary complex is crucial, it may not always guarantee successful protein degradation. The dynamics of the PROTAC-induced degradation complex play a key role in ubiquitination and subsequent degradation. In this study, we computationally modelled protein complex structures and dynamics associated with a series of PROTACs featuring different linkers to investigate why these PROTACs, all of which formed ternary complexes with Cereblon (CRBN) E3 ligase and the target protein bromodomain-containing protein 4 (BRD4(BD1)), exhibited varying degrees of degradation potency. We constructed the degradation machinery complexes with Culling-Ring Ligase 4A (CRL4A) E3 ligase scaffolds. Through atomistic molecular dynamics simulations, we illustrated how PROTAC-dependent protein dynamics facilitating the arrangement of surface lysine residues of BRD4(BD1) into the catalytic pocket of E2/ubiquitin cascade for ubiquitination. Despite featuring identical warheads in this PROTAC series, the linkers were found to affect the residue-interaction networks, and thus governing the essential motions of the entire degradation machine for ubiquitination. These findings offer a structural dynamic perspective on ligand-induced protein degradation, providing insights to guide future PROTAC design endeavors.
引用
收藏
页数:24
相关论文
共 50 条
  • [1] Structural Basis of Conformational Dynamics in the PROTAC-Induced Protein Degradation
    Zhao, Hongtao
    CHEMMEDCHEM, 2024, 19 (14)
  • [2] Kinetic Modeling of PROTAC-Induced Protein Degradation
    Zhao, Hongtao
    Narjes, Frank
    CHEMMEDCHEM, 2023, 18 (24)
  • [3] PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer
    Raina, Kanak
    Lu, Jing
    Qian, Yimin
    Altieri, Martha
    Gordon, Deborah
    Rossi, Ann Marie K.
    Wang, Jing
    Chen, Xin
    Dong, Hanqing
    Siu, Kam
    Winkler, James D.
    Crew, Andrew P.
    Crews, Craig M.
    Coleman, Kevin G.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (26) : 7124 - 7129
  • [4] Protac-Induced Protein Degradation in Drug Discovery: Breaking the Rules or Just Making New Ones?
    Churcher, Ian
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (02) : 444 - 452
  • [5] Targeted protein degradation: elements of PROTAC design
    Paiva, Stacey-Lynn
    Crews, Craig M.
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2019, 50 : 111 - 119
  • [6] Targeted Protein Degradation: Design Considerations for PROTAC Development
    Tran, Nathan L.
    Leconte, Georges A.
    Ferguson, Fleur M.
    CURRENT PROTOCOLS, 2022, 2 (12):
  • [7] From PROTAC to TPD: Advances and Opportunities in Targeted Protein Degradation
    Wang, Siqi
    He, Fuchu
    Tian, Chunyan
    Sun, Aihua
    PHARMACEUTICALS, 2024, 17 (01)
  • [8] PROTAC'ing oncoproteins: targeted protein degradation for cancer therapy
    Kelm, Jeremy M. M.
    Pandey, Deepti S. S.
    Malin, Evan
    Kansou, Hussein
    Arora, Sahil
    Kumar, Raj
    Gavande, Navnath S. S.
    MOLECULAR CANCER, 2023, 22 (01)
  • [9] Beyond canonical PROTAC: biological targeted protein degradation (bioTPD)
    Huifang Wang
    Runhua Zhou
    Fushan Xu
    Kongjun Yang
    Liuhai Zheng
    Pan Zhao
    Guangwei Shi
    Lingyun Dai
    Chengchao Xu
    Le Yu
    Zhijie Li
    Jianhong Wang
    Jigang Wang
    Biomaterials Research, 27
  • [10] PROTAC: An Effective Targeted Protein Degradation Strategy for Cancer Therapy
    Qi, Si-Min
    Dong, Jinyun
    Xu, Zhi-Yuan
    Cheng, Xiang-Dong
    Zhang, Wei-Dong
    Qin, Jiang-Jiang
    FRONTIERS IN PHARMACOLOGY, 2021, 12